GREAT
COMPANY
Towards Corporate Value of 50 Trillion
in 2030
Stock Status
As a global leader in the health industry,
we are increasing corporate value
across various business areas
Total Number of Shares
Type | Common stock | Preferred stock | Total |
---|---|---|---|
Total issued | 47,028,210 | 2,514,860 | 49,543,070 |
Treasury stock | 2,094,020 | 2,047,319 | 4,141,339 |
In circulation | 44,934,190 | 467,541 | 45,401,731 |
Type | Stock Type | FY2022 | FY2021 | FY2020 |
---|---|---|---|---|
Face price per share (KRW) | 500 | 500 | 500 | |
(Consolidated) net income (in KRW million) | 32,823 | 55,270 | 170,960 | |
(Separate) net income (in KRW million) | 16,120 | 35,663 | 50,376 | |
(Consolidated) net income per share (KRW)* | 727 | 1,222 | 3,793 | |
Total payout in cash (in KRW million) | 13,622 | 18,162 | 22,702 | |
(Consolidated) propensity to cash payout (%) | 41.5 | 32.9 | 13.3 | |
Cash dividend yield ratio (%) | Common stock | 1.8 | 1.5 | 1.4 |
Preferred stock | - | - | - | |
Weekly Cash dividend ratio (KRW) | Common stock | 300 | 400 | 500 |
Preferred stock | 305 | 405 | 505 |
Summary Consolidated Income Statement
Type | 2022 | 2021 | 2020 |
---|---|---|---|
Sales | 2,079,560 | 1,840,559 | 1,719,326 |
Operating Profit | 71,160 | 86,244 | 70,732 |
Net Income Before Income Tax Expenses | 29,629 | 180,013 | 107,919 |
Net Income | 58,897 | 127,658 | 179,995 |
Total Comprehensive Income | 80,610 | 155,208 | 184,695 |
Summary Consolidated Statement of Financial Position
Type | 2022 | 2021 | 2020 |
---|---|---|---|
[Current assets] | 1,261,978 | 1,424,864 | 1,535,804 |
[Fixed assets] | 2,330,082 | 2,071,970 | 1,705,398 |
Total assets | 3,592,060 | 3,496,834 | 3,241,202 |
[Current liabilities] | 1,052,354 | 925,913 | 1,102,777 |
[Fixed liabilities] | 572,663 | 660,192 | 464,924 |
Total liabilities | 1,625,017 | 1,586,105 | 1,567,701 |
Total capital | 1,967,043 | 1,910,729 | 1,673,501 |
신용등급
구분 | 한국기업평가 | 신용등급 | A+ (2020년) |
---|---|---|---|
NICE 신용평가 | AA- (2020년) |
Rejection of e-mail collection
GC는 이메일 수집을 거부합니다
본 웹사이트에 게시된 이메일 주소가 전자우편 수집 프로그램이나 그 밖의 기술적 장치를 이용하여 무단으로 이메일 주소를 수집하는 행위를 거부하며, 이를 위반시 정보통신망 이용촉진 및 정보보호 등에 관한 법률에 의해 형사처벌됨을 유념하시기 바랍니다.
게시일: 2003년 9월 1일
GC FAMILY SITE
Pharmaceutical
PharmaceuticalHealthcare
HealthcareDiagnosis
DiagnosisOverseas
OverseasGC China Pharm
GC Biopharma do Brasil
Foundation
FoundationMoreover
MoreoverGC Invacfarm